About Me
Dr. Maia Kayal is an Assistant Professor in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai and The Susan and Leonard Feinstein Inflammatory Bowel Disease (IBD) Center. She specializes in the care of patients with gastrointestinal illnesses with a focus on ulcerative colitis and Crohn's disease. She graduated from New York University School of Medicine with the highest honors and was inducted into the Alpha Omega Alpha national medical honor society. She completed her internal medicine residency at Columbia University Medical Center-New York Presbyterian Hospital and fellowship training in gastroenterology at the Mount Sinai Hospital, where she served as chief gastroenterology fellow. Dr. Kayal's research in inflammatory conditions of the ileal pouch in ulcerative colitis patients has been published in peer-reviewed journals and presented nationally. Dr. Kayal's current research interests include prediction and risk stratification in ulcerative colitis patients who need surgery.
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
Dr. Maia Kayal is an Assistant Professor in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai and The Susan and Leonard Feinstein Inflammatory Bowel Disease (IBD) Center. She specializes in the care of patients with gastrointestinal illnesses with a focus on ulcerative colitis and Crohn's disease. She graduated from New York University School of Medicine with the highest honors and was inducted into the Alpha Omega Alpha national medical honor society. She completed her internal medicine residency at Columbia University Medical Center-New York Presbyterian Hospital and fellowship training in gastroenterology at the Mount Sinai Hospital, where she served as chief gastroenterology fellow. Dr. Kayal's research in inflammatory conditions of the ileal pouch in ulcerative colitis patients has been published in peer-reviewed journals and presented nationally. Dr. Kayal's current research interests include prediction and risk stratification in ulcerative colitis patients who need surgery.
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Education
MD, New York University School of Medicine
Residency, Internal Medicine
New York Presbyterian Hospital/Columbia University
Fellowship, Gastroenterology
Mount Sinai Hospital
Certifications
American Board of Internal Medicine
Awards
Phi Beta Kappa
Alpha Omega Alpha
New York University School of Medicine Hippolyte Wertheim Award
Columbia University Medical Center-New York Presbyterian, Associates in Internal Medicine Provider of the Month
United European Gastroenterology Oral Free Paper Prize
National Institutes of Health-National Medical Association Fellow
American College of Gastroenterology Young Physicians Leadership Scholar
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- The Susan and Leonard Feinstein IBD Center17 E. 102nd Street, 5th Floor, New York, NY, 10029
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Kayal during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- IBD Horizons
- Fresenius Kabi
- Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
- Cornerstones
- Bristol-Meyers Company
- Scholars in Medicine
- AbbVie, Inc.
- MJH Life Sciences
- GoodRx
- Med Learning Group
- Excellence in Gastroenterology Education
- Pfizer Inc., U.S. Pharmaceuticals Group
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Kayal during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- IBD Horizons
- Fresenius Kabi
- Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
- Cornerstones
- Bristol-Meyers Company
- Scholars in Medicine
- AbbVie, Inc.
- MJH Life Sciences
- GoodRx
- Med Learning Group
- Excellence in Gastroenterology Education
- Pfizer Inc., U.S. Pharmaceuticals Group
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.